𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Absence of ESR1 amplification in a series of breast cancers

✍ Scribed by José Adélaïde; Pascal Finetti; Emmanuelle Charafe-Jauffret; Julien Wicinski; Jocelyne Jacquemier; Christos Sotiriou; François Bertucci; Daniel Birnbaum; Max Chaffanet

Publisher
John Wiley and Sons
Year
2008
Tongue
French
Weight
282 KB
Volume
123
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Amplification of fgfr4 gene in human bre
Amplification of fgfr4 gene in human breast and gynecological cancers
✍ Susanna Jaakkola; Paula Salmikangas; Stella Nylund; Pentti Lehtovirta; Heli Neva 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 777 KB

We have investigated gene amplification of fibroblast growth factor receptor-4 (FGFM) gene in 30 primary breast tumor samples and 15 gynecological tumor samples. Ten percent of

Frequent amplification and overexpressio
Frequent amplification and overexpression of CCND1 in male breast cancer
✍ Maarit Bärlund; Tuula Kuukasjärvi; Kirsi Syrjäkoski; Anssi Auvinen; Anne Kallion 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 117 KB

## Abstract Genetic events underlying the pathogenesis of breast cancer have been studied extensively and several clinically significant markers have been identified. For example, amplification and overexpression of the __ERBB2__ oncogene is associated with poor prognosis in breast cancer and __ERB

The significance of oncogene amplificati
The significance of oncogene amplification in primary breast cancer
✍ R. Seshadri; C. Matthews; A. Dobrovic; D. J. Horsfall 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 311 KB

Alterations in the gene copy numbers of the proto-oncogenes HERZ/neu and c-myc in primary human breast cancer investigated in 73 patients. We detected amplification of H€R2/ neu in 17 patient samples and amplification of c-myc in I I, while amplification of both was seen in 6 samples. There was no c

Absence of Epstein-Barr virus EBER-1 tra
Absence of Epstein-Barr virus EBER-1 transcripts in an epidemiologically diverse group of breast cancers
✍ Sally L. Glaser; Richard F. Ambinder; Joseph A. DiGiuseppe; Pamela L. Horn-Ross; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 45 KB

Epstein-Barr virus (EBV), a ubiquitous herpesvirus associated with certain lymphomas and carcinomas, has been identified within the malignant cells of a small proportion of breast tumors. As breast cancer is a very common malignancy in women, a pathogenetic role of EBV for even a subgroup of patient

Co-amplification of 8p12 and 11q13 in br
Co-amplification of 8p12 and 11q13 in breast cancers is not the result of a single genomic event
✍ Anna L. Paterson; Jessica C. M. Pole; Katherine A. Blood; Maria J. Garcia; Susan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 885 KB

## Abstract Epithelial cancers frequently have multiple amplifications, and particular amplicons tend to occur together. These co‐amplifications have been suggested to result from amplification of pre‐existing junctions between two chromosomes, that is, translocation junctions. We investigated this

Characterization of topoisomerase IIα ge
Characterization of topoisomerase IIα gene amplification and deletion in breast cancer
✍ Tero A.H. Järvinen; Minna Tanner; Maarit Bärlund; Åke Borg; Jorma Isola 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB 👁 1 views

Topoisomerase II␣ (TOP2A) is a key enzyme in DNA replication and a molecular target for many important anticancer drugs. TOP2A is amplified or deleted together with amplification of the closely located ERBB2/HER-2/neu oncogene in breast cancer. We characterized the copy number aberrations of TOP2A a